HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Marien Selected Research

dexefaroxan

6/2006The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells.
4/2002Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Marien Research Topics

Disease

4Parkinson Disease (Parkinson's Disease)
11/2008 - 12/2003
3Alzheimer Disease (Alzheimer's Disease)
06/2006 - 04/2002
2Memory Disorders (Memory Loss)
12/2009 - 04/2002
1Cognitive Dysfunction
12/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2004

Drug/Important Bio-Agent (IBA)

2Cholinergic Agents (Cholinergics)IBA
12/2009 - 06/2005
2dexefaroxanIBA
06/2006 - 04/2002
1dimethylaminoethanol pyroglutamateIBA
12/2009
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2009
1Choline (Choline Chloride)IBA
12/2009
1Scopolamine (Hyoscine)FDA Link
12/2009
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2008
1Caffeine (No Doz)FDA LinkGeneric
10/2008
1Oxidopamine (6 Hydroxydopamine)IBA
06/2005
1Pharmaceutical PreparationsIBA
01/2004
1N-Methylaspartate (NMDA)IBA
01/2004
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2004
1Adrenergic Receptors (Adrenergic Receptor)IBA
12/2003
1NeurotoxinsIBA
04/2002

Therapy/Procedure

1Therapeutics
12/2003